Lipocine Inc (LPCN): With stocks having issues like these not...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Lipocine Inc (LPCN)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	5
Posts	2466
Boards Moderated	0
Alias Born	08/16/2016

Re: grizzly2314 post# 378

Friday, 01/18/2019 5:41:37 PM

Friday, January 18, 2019 5:41:37 PM

With stocks having issues like these noted below, it's really hard for retail investors to make a profit...

High, selling, general and administrative costs
High salaries and bonuses
Toxic debt
Stock dilution, reverse splits or warrants
Share structure, outstanding shares vs. authorized shares, vs. preferred shares
CEO's missing Q guidance's
CRL letters from the FDA
Outright rejection from the FDA
Lawsuits
Failed phase I, II or III trials
Negative publicity, even it's it fake news
Competition from other companies
OTC companies not being regulated

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent LPCN News

Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 01:35:10 PM
Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek® • PR Newswire (US) • 09/05/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 03:23:16 PM
Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference • PR Newswire (US) • 08/27/2024 12:00:00 PM
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2024 • PR Newswire (US) • 08/08/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 10:20:27 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 10:19:03 AM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/07/2024 08:05:52 PM
Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal Study • PR Newswire (US) • 06/25/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 01:00:30 PM
Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024 • PR Newswire (US) • 06/10/2024 12:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:48:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:45:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:43:25 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:41:45 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:39:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:32:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:12 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/03/2024 09:09:23 PM
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024 • PR Newswire (US) • 05/09/2024 12:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 10:06:19 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 10:03:08 AM
Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024 • PR Newswire (US) • 05/08/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 10:15:30 AM
Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154 • PR Newswire (US) • 05/01/2024 12:00:00 PM

More LPCN News

InvestorsHub NewsWire

FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM

FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM

Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM

HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow